International Cancer Conference Journal最新文献

筛选
英文 中文
Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case report. 新型辅助治疗nivolumab加ipilimumab后机器人辅助腹腔镜根治性肾切除术完全切除伴有下腔静脉癌栓的肉瘤样肾细胞癌1例
IF 0.7
International Cancer Conference Journal Pub Date : 2023-08-19 eCollection Date: 2024-01-01 DOI: 10.1007/s13691-023-00627-5
Ayaka Tsuchiyama, Kojiro Ohba, Hiromi Nakanishi, Takuji Yasuda, Yuichiro Nakamura, Hirokazu Kurohama, Kensuke Mitsunari, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura
{"title":"Sarcomatoid renal cell carcinoma with an inferior vena cava tumor thrombus that was completely resected by robot-assisted laparoscopic radical nephrectomy after neoadjuvant therapy nivolumab plus ipilimumab: a case report.","authors":"Ayaka Tsuchiyama, Kojiro Ohba, Hiromi Nakanishi, Takuji Yasuda, Yuichiro Nakamura, Hirokazu Kurohama, Kensuke Mitsunari, Tomohiro Matsuo, Yasushi Mochizuki, Ryoichi Imamura","doi":"10.1007/s13691-023-00627-5","DOIUrl":"10.1007/s13691-023-00627-5","url":null,"abstract":"<p><p>We here present a patient with a sarcomatoid renal cell carcinoma complicated by inferior vena cava tumor thrombus that we treated with nivolumab plus ipilimumab. This resulted in shrinkage of the tumor, enabling complete resection by robot-assisted laparoscopic radical nephrectomy. The patient is still alive with no evidence of recurrence.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"1 1","pages":"6-10"},"PeriodicalIF":0.7,"publicationDate":"2023-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10764663/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41342673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiologic and pathologic correlation of a renal venous hemangioma. 肾静脉血管瘤的放射学和病理学相关性。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-08-04 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00626-6
Alperen Elek, Jung Woo Kwon, Sena Ertugrul, Nisa Cem Oren
{"title":"Radiologic and pathologic correlation of a renal venous hemangioma.","authors":"Alperen Elek, Jung Woo Kwon, Sena Ertugrul, Nisa Cem Oren","doi":"10.1007/s13691-023-00626-6","DOIUrl":"10.1007/s13691-023-00626-6","url":null,"abstract":"<p><p>Renal hemangiomas, including the rare subtype of venous hemangioma, are typically non-cancerous, often asymptomatic, and usually discovered incidentally during imaging studies. Here, we report a unique case of a 59-year-old African-American female with a renal venous hemangioma that initially mimicked papillary-type renal cell carcinoma (RCC-pt) on imaging studies. The patient's presentation included a long history of rectal bleeding and an incidental discovery of a hypoattenuating mass in the left kidney during a contrast-enhanced CT scan. Renal MRI revealed a 3.5 cm left renal lower pole mass, presenting as heterogeneously hyperintense on T1-weighted images and hypointense on T2-weighted images, with gradual mild enhancement post-contrast. Subsequent total nephrectomy confirmed the histopathological diagnosis of a venous hemangioma. This case underlines the need for recognizing unique imaging features of renal venous hemangiomas, contributing to the differential diagnosis of T2 dark hypoenhancing renal masses. Correct interpretation may prevent unnecessary invasive procedures and operations, thereby improving patient management and outcomes.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"227-232"},"PeriodicalIF":0.5,"publicationDate":"2023-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuroendocrine tumor of the minor duodenal papilla with lymph node metastasis: a case report and literature review. 十二指肠小乳头神经内分泌肿瘤伴淋巴结转移:一例报告和文献复习。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-07-30 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00624-8
Hideo Ota, Shigekazu Yokoyama, Kazunori Yanagawa, Sadaharu Iio, Mutsumi Fukunaga
{"title":"Neuroendocrine tumor of the minor duodenal papilla with lymph node metastasis: a case report and literature review.","authors":"Hideo Ota, Shigekazu Yokoyama, Kazunori Yanagawa, Sadaharu Iio, Mutsumi Fukunaga","doi":"10.1007/s13691-023-00624-8","DOIUrl":"10.1007/s13691-023-00624-8","url":null,"abstract":"<p><p>Whether pancreatoduodenectomy or papillary resection should be performed to achieve curative treatment for neuroendocrine tumors of the minor duodenal papilla with a diameter of ≤2 cm is controversial. We report a 35-year-old male patient with a rare case of a neuroendocrine tumor of the minor duodenal papilla. The patient was referred to our hospital from a different clinic for dilatation of his minor duodenal papilla. Duodenoscopy revealed a smooth mass of 2 cm in diameter in the minor papilla, and the biopsy specimen was diagnosed as neuroendocrine tumor G1. The patient underwent subtotal stomach-preserving pancreatoduodenectomy. Histological evaluation showed a single nodule of 15 mm in diameter in the mucosa with metastasis to the regional lymph node. The tumor cells exhibited immunoactivity against synaptophysin and chromogranin A. The molecular immunology Borstel-1 index was less than 1%, and the grade was neuroendocrine tumor G1. We reviewed the characteristics of 24 cases of patients who underwent PD for NETs of the minor duodenal papilla in English literature. In 22 of these cases, the tumor depth was described. Lymph node metastasis was observed in none of the three cases (0%) in which the tumor was limited to the intra-sphincter; however, it was noted in three (30%) of the 10 cases in which the tumor had invaded the duodenal submucosa and in eight (89%) of the nine cases in which the tumor had invaded the muscularis propria, pancreas, peripancreatic/periduodenal tissues, or duodenal serosa. Making a definitive diagnosis preoperatively or intraoperatively whether the tumor invades beyond the sphincter or not and whether regional lymph node metastasis is present may not be possible. Therefore, we believe that pancreatoduodenectomy with lymphadenectomy is preferable for curative treatment of neuroendocrine tumors of the minor duodenal papilla.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"255-262"},"PeriodicalIF":0.5,"publicationDate":"2023-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421825/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10002504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report. pembrolizumab免疫治疗林奇综合征引起的远端十二指肠腺癌后的病理学完全反应:一例报告。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-07-26 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00622-w
Shinichiro Ikeda, Qingjiang Hu, Keita Natsugoe, Tomoya Harima, Yasushi Tanaka, Izumi Kinoshita, Kentaro Nonaka, Sho Nambara, Ryota Nakanishi, Tomonori Nakanoko, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi
{"title":"A pathological complete response after immunotherapy with pembrolizumab for distal duodenal adenocarcinoma caused by Lynch syndrome: a case report.","authors":"Shinichiro Ikeda, Qingjiang Hu, Keita Natsugoe, Tomoya Harima, Yasushi Tanaka, Izumi Kinoshita, Kentaro Nonaka, Sho Nambara, Ryota Nakanishi, Tomonori Nakanoko, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yoshinao Oda, Tomoharu Yoshizumi","doi":"10.1007/s13691-023-00622-w","DOIUrl":"10.1007/s13691-023-00622-w","url":null,"abstract":"<p><p>Primary adenocarcinoma of the duodenum is a rare neoplasm that is often microsatellite instability-high (MSI-H). Pembrolizumab, a monoclonal antibody, has been recently approved in Japan for treatment of MSI-H solid tumors. Lynch syndrome is a frequent hereditary cancer predisposition syndrome. It is linked to an increased risk of various types of cancer, including colorectal and endometrial cancer, and is closely related to MSI-H. We present the case of a 55-year-old woman who was diagnosed with duodenal cancer. Biopsy findings revealed MSI-H, and pembrolizumab therapy was initiated because the tumor was in contact with the left renal vein and had metastasized to the mesenteric lymph nodes of the small intestine. Subsequently, after completing two courses of pembrolizumab therapy, the patient developed duodenal stenosis and underwent surgery. Pathological analysis of the resected specimen revealed no evidence of malignancy. Given the patient's previous cancer history and the occurrence of cancer in close relatives, genetic testing of peripheral blood was performed, which revealed the diagnosis of Lynch syndrome. Furthermore, the variant responsible for Lynch syndrome was found to be a mutation of NM_000251.3:c.211 + 1G > C in <i>MSH2</i>.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"279-284"},"PeriodicalIF":0.5,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report. 一例卵巢癌症患者pembrolizumab治疗期间心脏压塞:病例报告。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-07-05 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00621-x
Wei-Ting Sung, Kunihiro Sakai, Haruka Etou, Rikiko Yamamichi, Tomoko Yoneda, Toshiaki Matsuura, Tomoyoshi Maruyama, Daisuke Nishi
{"title":"Cardiac tamponade during pembrolizumab treatment in a patient with ovarian cancer: a case report.","authors":"Wei-Ting Sung, Kunihiro Sakai, Haruka Etou, Rikiko Yamamichi, Tomoko Yoneda, Toshiaki Matsuura, Tomoyoshi Maruyama, Daisuke Nishi","doi":"10.1007/s13691-023-00621-x","DOIUrl":"10.1007/s13691-023-00621-x","url":null,"abstract":"<p><p>We present the case of a 39-year-old woman with platinum-resistant ovarian cancer who was treated with pembrolizumab. After five cycles of pembrolizumab treatment, she suddenly developed cardiac tamponade with a pleural effusion. The malignant pericardial and pleural effusion had increased, while the other malignant lesions had diminished in size. After pericardial and pleural drainage, no re-accumulation occurred. Pembrolizumab was continued and the patient did not have tumor progression for > 20 months. In some patients with pembrolizumab-induced cardiac tamponade, continuation of pembrolizumab treatment may be possible if other lesions decrease in size and the pericardial effusion can be controlled after drainage.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"305-310"},"PeriodicalIF":0.5,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421831/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10002503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case of pseudomyxoma peritonei with Morgagni hernia. 一例罕见的腹膜假性粘液瘤合并Morgagni疝。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-07-05 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00614-w
Toru Imagami, Yasumitsu Oe, Byonggu An, Nobuyuki Takao, Takeshi Togawa, Akiyoshi Mizumoto
{"title":"A rare case of pseudomyxoma peritonei with Morgagni hernia.","authors":"Toru Imagami, Yasumitsu Oe, Byonggu An, Nobuyuki Takao, Takeshi Togawa, Akiyoshi Mizumoto","doi":"10.1007/s13691-023-00614-w","DOIUrl":"10.1007/s13691-023-00614-w","url":null,"abstract":"<p><p>Both pseudomyxoma peritonei and Morgagni hernias in adults are rare clinical conditions. A 70-year-old woman who was diagnosed with pseudomyxoma peritonei with Morgagni hernia underwent cytoreductive surgery and primary repair. Pseudomyxoma peritonei causes increased intra-abdominal pressure that may lead to acquired congenital diaphragmatic hernia when there is a local fragility in the diaphragmatic musculature. Parietal peritonectomy of the right diaphragmatic peritoneum can safely remove the hernia sac. The high rate of infections associated with cytoreductive surgery causes hesitation for concurrent mesh repair for Morgagni hernia. This is the first report of pseudomyxoma peritonei with Morgagni hernia. Cytoreductive surgery including parietal peritonectomy of the right diaphragmatic peritoneum plus primary repair of hernial defect was performed safely and successfully, which achieved positive short-term results for patients with pseudomyxoma peritonei-associated Morgagni hernia.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"263-267"},"PeriodicalIF":0.5,"publicationDate":"2023-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421794/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10002505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia. FGFR2融合基因阳性的肝内胆管癌对培咪嗪尼有反应并引起低磷血症。
IF 0.5
International Cancer Conference Journal Pub Date : 2023-07-03 eCollection Date: 2023-10-01 DOI: 10.1007/s13691-023-00619-5
Yoshinori Kikuchi, Kazuhisa Yamaguchi, Ryo Shimizu, Yuu Matsumoto, Yasuko Kurose, Naoki Okano, Yuichirou Otsuka, Kazutoshi Shibuya, Takahisa Matsuda, Hideaki Shimada
{"title":"Intrahepatic cholangiocarcinoma with FGFR2 fusion gene positive that responded to pemigatinib and caused hypophosphatemia.","authors":"Yoshinori Kikuchi, Kazuhisa Yamaguchi, Ryo Shimizu, Yuu Matsumoto, Yasuko Kurose, Naoki Okano, Yuichirou Otsuka, Kazutoshi Shibuya, Takahisa Matsuda, Hideaki Shimada","doi":"10.1007/s13691-023-00619-5","DOIUrl":"10.1007/s13691-023-00619-5","url":null,"abstract":"<p><p>Intrahepatic cholangiocarcinoma is a condition with a poor prognosis. Traditionally, there was no cure unless important drugs such as gemcitabine, cisplatin, and tegafur/gimeracil/uracil potassium showed efficacy. Pemigatinib has recently become accessible for the treatment of intrahepatic cholangiocarcinoma with FGFR2 fusion or rearrangement gene abnormalities. Hyperphosphatemia is typically linked to pemigatinib. In the current case, pemigatinib was used to effectively treat a 48-year-old woman, and hypophosphatemia was observed. Patients with intrahepatic cholangiocarcinoma should undergo aggressive cancer multigene panel testing as well as careful monitoring of serum phosphorus levels.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 4","pages":"285-290"},"PeriodicalIF":0.5,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421826/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10000074","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abscopal effect of radiation in metastatic esophageal carcinoma: fourth reported case. 放疗在转移性食管癌中的作用:第4例报告。
IF 0.7
International Cancer Conference Journal Pub Date : 2023-07-01 DOI: 10.1007/s13691-023-00605-x
Rituparna Biswas, Rajesh Jindel, Anirban Halder, Koushik Sen, Apurba Kabasi
{"title":"Abscopal effect of radiation in metastatic esophageal carcinoma: fourth reported case.","authors":"Rituparna Biswas,&nbsp;Rajesh Jindel,&nbsp;Anirban Halder,&nbsp;Koushik Sen,&nbsp;Apurba Kabasi","doi":"10.1007/s13691-023-00605-x","DOIUrl":"https://doi.org/10.1007/s13691-023-00605-x","url":null,"abstract":"<p><p>Abscopal or bystander effect of radiotherapy is a rare and unpredictable outcome encountered during treatment of metastatic cancer where tumor regression is observed distant from irradiated volume. While it has been more frequently reported with malignancies like melanoma, lymphoma, and renal cell carcinoma, data regarding metastatic esophageal cancers are sparse. We describe a case of abscopal regression of distant mediastinal and upper abdominal lymph nodes in a 65-year-old gentleman whose primary esophageal tumor was irradiated with hypo-fractionated radiotherapy in an attempt to achieve local palliation. Our case study emphasizes the systemic benefit of local radiotherapy and the need for future research to investigate its utility as this clinical event poses widespread response in an otherwise dismal Stage-IV cancer with minimal treatment-related side effects.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 3","pages":"200-204"},"PeriodicalIF":0.7,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9580266","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation. 修正:mRNA - 1273加强接种后对侧上肢出现的COVID臂。
IF 0.7
International Cancer Conference Journal Pub Date : 2023-07-01 DOI: 10.1007/s13691-023-00600-2
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Kan Yonemori
{"title":"Correction to: COVID arm that appeared in the contralateral upper extremity after mRNA‑1273 booster inoculation.","authors":"Tomomi Sanomachi,&nbsp;Hitomi Sumiyoshi Okuma,&nbsp;Kan Yonemori","doi":"10.1007/s13691-023-00600-2","DOIUrl":"https://doi.org/10.1007/s13691-023-00600-2","url":null,"abstract":"<p><p>[This corrects the article DOI: 10.1007/s13691-023-00598-7.].</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 3","pages":"220"},"PeriodicalIF":0.7,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015125/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9529303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation. mRNA-1273加强接种后对侧上肢出现的COVID臂。
IF 0.7
International Cancer Conference Journal Pub Date : 2023-07-01 DOI: 10.1007/s13691-023-00598-7
Tomomi Sanomachi, Hitomi Sumiyoshi Okuma, Kan Yonemori
{"title":"COVID arm that appeared in the contralateral upper extremity after mRNA-1273 booster inoculation.","authors":"Tomomi Sanomachi,&nbsp;Hitomi Sumiyoshi Okuma,&nbsp;Kan Yonemori","doi":"10.1007/s13691-023-00598-7","DOIUrl":"https://doi.org/10.1007/s13691-023-00598-7","url":null,"abstract":"<p><p>We report the findings of a 60-year-old female patient with metastatic breast cancer who presented with severe edema and neuralgia in the contralateral arm after receiving the third COVID-19 vaccine dose. The patient did not report any reaction to the first two doses of the BNT162b2 (Pfizer-BioNTech) vaccine. However, after a booster dose with the mRNA-1273 (Moderna) vaccine, the patient developed a high fever persisting for one week after the shot, and sequential severe swelling, inflammation, and pain in the contralateral arm lasting for three weeks.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"12 3","pages":"216-219"},"PeriodicalIF":0.7,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9521391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信